BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32481602)

  • 1. Multiple Functions of Fubp1 in Cell Cycle Progression and Cell Survival.
    Kang M; Kim HJ; Kim TJ; Byun JS; Lee JH; Lee DH; Kim W; Kim DY
    Cells; 2020 May; 9(6):. PubMed ID: 32481602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2.
    Kang M; Lee SM; Kim W; Lee KH; Kim DY
    Biochem Biophys Res Commun; 2019 Apr; 512(1):93-99. PubMed ID: 30871777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas-mediated Fubp1 silencing disrupts circadian oscillation of Per1 protein via downregulating Syncrip expression.
    Kim TJ; Sung JH; Shin JC; Kim DY
    Cell Biol Int; 2020 Feb; 44(2):424-432. PubMed ID: 31535751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The master regulator FUBP1: its emerging role in normal cell function and malignant development.
    Debaize L; Troadec MB
    Cell Mol Life Sci; 2019 Jan; 76(2):259-281. PubMed ID: 30343319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.
    Debaize L; Jakobczyk H; Avner S; Gaudichon J; Rio AG; Sérandour AA; Dorsheimer L; Chalmel F; Carroll JS; Zörnig M; Rieger MA; Delalande O; Salbert G; Galibert MD; Gandemer V; Troadec MB
    Nucleic Acids Res; 2018 Nov; 46(21):11214-11228. PubMed ID: 30500954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcriptional regulator FUBP1 influences disease outcome in murine and human myeloid leukemia.
    Hoang VT; Verma D; Godavarthy PS; Llavona P; Steiner M; Gerlach K; Michels BE; Bohnenberger H; Wachter A; Oellerich T; Müller-Kuller U; Weissenberger E; Voutsinas JM; Oehler VG; Farin HF; Zörnig M; Krause DS
    Leukemia; 2019 Jul; 33(7):1700-1712. PubMed ID: 30635626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of FUBP1 is associated with human cervical carcinoma development and prognosis.
    Ma C; Huang Z; Wu Z; Di C; Lin X; Huang M; Hong H; Yin H
    Life Sci; 2021 Mar; 269():119098. PubMed ID: 33476628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNPO1-Mediated Nuclear Import of FUBP1 Contributes to Tumor Immune Evasion by Increasing NRP1 Expression in Cervical Cancer.
    Yang B; Chen J; Teng Y
    J Immunol Res; 2021; 2021():9994004. PubMed ID: 33987449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental Roles of FUSE Binding Protein 1 (
    Aryal YP; Neupane S; Kim TY; Lee ES; Pokhrel NK; Yeon CY; Kim JY; An CH; An SY; Park EK; Ha JH; Jung JK; Yamamoto H; Cho SW; Lee S; Kim DY; Kwon TY; Lee Y; Sohn WJ; Kim JY
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
    Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Far Upstream Element-Binding Protein 1 (FUBP1) Promotes Tumor Proliferation and Tumorigenesis of Clear Cell Renal Cell Carcinoma.
    Duan J; Bao X; Ma X; Zhang Y; Ni D; Wang H; Zhang F; Du Q; Fan Y; Chen J; Wu S; Li X; Gao Y; Zhang X
    PLoS One; 2017; 12(1):e0169852. PubMed ID: 28076379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation.
    Steiner M; Schneider L; Yillah J; Gerlach K; Kuvardina ON; Meyer A; Maring A; Bonig H; Seifried E; Zörnig M; Lausen J
    PLoS One; 2019; 14(1):e0210515. PubMed ID: 30653565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Far upstream element -binding protein 1 (FUBP1) participates in the malignant process and glycolysis of colon cancer cells by combining with c-Myc.
    Wang S; Wang Y; Li S; Nian S; Xu W; Liang F
    Bioengineered; 2022 May; 13(5):12115-12126. PubMed ID: 35546072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of RNA Interference Inhibiting the Expression of the FUBP1 Gene on Biological Function of Gastric Cancer Cell Line SGC7901.
    Zhang F; Zhang Y; Wang Y
    Turk J Gastroenterol; 2021 Nov; 32(11):923-931. PubMed ID: 34872893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Far upstream element-binding protein 1 facilitates hepatocellular carcinoma invasion and metastasis.
    Fu PY; Hu B; Ma XL; Tang WG; Yang ZF; Sun HX; Yu MC; Huang A; Hu JW; Zhou CH; Fan J; Xu Y; Zhou J
    Carcinogenesis; 2020 Jul; 41(7):950-960. PubMed ID: 31587040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus 5 E1A-Mediated Suppression of p53 via FUBP1.
    Frost JR; Mendez M; Soriano AM; Crisostomo L; Olanubi O; Radko S; Pelka P
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSE.
    Khageh Hosseini S; Kolterer S; Steiner M; von Manstein V; Gerlach K; Trojan J; Waidmann O; Zeuzem S; Schulze JO; Hahn S; Steinhilber D; Gatterdam V; Tampé R; Biondi RM; Proschak E; Zörnig M
    Biochem Pharmacol; 2017 Dec; 146():53-62. PubMed ID: 29031818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression.
    Yang L; Zhu JY; Zhang JG; Bao BJ; Guan CQ; Yang XJ; Liu YH; Huang YJ; Ni RZ; Ji LL
    Tumour Biol; 2016 Mar; 37(3):4115-26. PubMed ID: 26490982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of far upstream element-binding protein 1 correlates with c-Myc expression in sacral chordomas and is associated with tumor progression and poor prognosis.
    Wen H; Ma H; Li P; Zheng J; Yu Y; Lv G
    Biochem Biophys Res Commun; 2017 Sep; 491(4):1047-1054. PubMed ID: 28780352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative structural analyses and nucleotide-binding characterization of the four KH domains of FUBP1.
    Ni X; Knapp S; Chaikuad A
    Sci Rep; 2020 Aug; 10(1):13459. PubMed ID: 32778776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.